FSNC acquires Adragos
FSN Capital VI has acquired a majority stake in Adragos, a European B2B contract developer and manufacturer for pharmaceuticals.
FSN Capital VI has acquired a majority stake in Adragos, a European B2B contract developer and manufacturer for pharmaceuticals.